Transfusion

Article	Citations
Use of convalescent plasma inCOVID‐19 patients with immunosuppression	68
Has the trend of declining blood transfusions in the United States ended? Findings of the 2019 National Blood Collection and Utilization Survey	53
SARS‐CoV‐2 seroprevalence among blood donors after the first COVID‐19 wave in Canada	50
Survey of group A plasma and low‐titer group O whole blood use in trauma resuscitation at adult civilian level 1 trauma centers in the US	46
COVID‐19 associated with severe autoimmune hemolytic anemia	44
SARS‐CoV‐2 antibody persistence in COVID‐19 convalescent plasma donors: Dependency on assay format and applicability to serosurveillance	42
Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing	41
Therapeutic plasma exchange for COVID‐19‐associated hyperviscosity	40
Production of anti‐SARS‐CoV‐2 hyperimmune globulin from convalescent plasma	39
Prehospital whole blood reduces early mortality in patients with hemorrhagic shock	39
COVID‐19 convalescent plasma: Interim recommendations from the AABB	38
HIV, HCV, and HBV incidence and residual risk in US blood donors before and after implementation of the 12‐month deferral policy for men who have sex with men	35
Blood donor obesity is associated with changes in red blood cell metabolism and susceptibility to hemolysis in cold storage and in response to osmotic and oxidative stress	33
Transition from room temperature to cold‐stored platelets for the preservation of blood inventories during the COVID‐19 pandemic	32
Transfusion‐related adverse reactions: Data from the National Healthcare Safety Network Hemovigilance Module — United States, 2013–2018	31
Severe autoimmune hemolytic anemia following receipt of SARS‐CoV‐2 mRNA vaccine	31
Extension of platelet shelf life with an improved bacterial testing algorithm	30
Fatty acid desaturase activity in mature red blood cells and implications for blood storage quality	28
Reduced sensitivity of PLASMIC and French scores for the diagnosis of thrombotic thrombocytopenic purpura in older individuals	28
The impact of temporary deferrals on future blood donation behavior across the donor life cycle	27
Outcomes and management of immune thrombocytopenia secondary to COVID‐19: Cleveland clinic experience	27
Comparability of six different immunoassays measuring SARS‐CoV‐2 antibodies with neutralizing antibody levels in convalescent plasma: From utility to prediction	27
A comparison of platelet function in cold‐stored whole blood and platelet concentrates	26
Exponential increase in neutralizing and spike specific antibodies following vaccination of COVID‐19 convalescent plasma donors	26
Adverse events after low titer group O whole blood versus component product transfusion in pediatric trauma patients: A propensity‐matched cohort study	25

ABO blood group and risk of COVID‐19 infection and complications: A systematic review and meta‐analysis	25
Injured recipients of low‐titer group O whole blood have similar clinical outcomes compared to recipients of conventional component therapy: A single‐center, retrospective study	25
Supplemental findings of the 2019 National Blood Collection and Utilization Survey	25
Cold storage of platelets in platelet additive solution maintains mitochondrial integrity by limiting initiation of apoptosis‐mediated pathways	25
Fatal sepsis associated with a storage container leak permitting platelet contamination with environmental bacteria after pathogen reduction	25
Donor screening question alternatives to men who have sex with men time deferral: Potential impact on donor deferral and discomfort	24
The Recipient Epidemiology and Donor Evaluation Study‐IV‐Pediatric (REDS‐IV‐P): A research program striving to improve blood donor safety and optimize transfusion outcomes across	23
The impact of COVID‐19 on academic productivity by female physicians and researchers in transfusion medicine	23
The transfusion management of beta thalassemia in the United States	23
Maintaining adequate donations and a sustainable blood supply: Lessons learned	23
Quantifying dynamic range in red blood cell energetics: Evidence of progressive energy failure during storage	23
A retrospective study assessing the characteristics of COVID‐19 convalescent plasma donors and donations	22
Babesia blood testing: the first‐year experience	21
Preoperative anemia management program reduces blood transfusion in elective cardiac surgical patients, improving outcomes and decreasing hospital length of stay	21
Lewis and ABO histo‐blood types and the secretor status of patients hospitalized with COVID‐19 implicate a role for ABO antibodies in susceptibility to infection with	21
How we secured a COVID‐19 convalescent plasma procurement scheme in Japan	21
De novo acquired hemophilia as an immune dysregulation phenomenon following SARS‐CoV‐2 infection	20
The healthy donor effect and survey participation, becoming a donor and donor career	20
Hepatitis B infections among blood donors in England between 2009 and 2018: Is an occult hepatitis B infection a risk for blood safety?	20
Continued stabilization of blood collections and transfusions in the United States: Findings from the 2021 National Blood Collection and Utilization Survey	20
Transfusion practices in a large cohort of hospitalized children	20
Assessing predictors of futility in patients receiving massive transfusions	19
Selecting COVID‐19 convalescent plasma for neutralizing antibody potency using a high‐capacity SARS‐CoV‐2 antibody assay	19
Joint Trauma System, Defense Committee on Trauma, and Armed Services Blood Program consensus statement on whole blood	19
Impact of different pathogen reduction technologies on the biochemistry, function, and clinical effectiveness of platelet concentrates: An updated view during a pandemic	19
Blood component utilization in COVID‐19 patients in New York City: Transfusions do not follow the curve	18
The effect of COVID‐19 on blood donation habits	18
HIV incidence and compliance with deferral criteria over three progressively shorter time deferrals for men who have sex with men in Canada	18
A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with	17
Treatment through a preoperative anemia clinic is associated with a reduction in perioperative red blood cell transfusion in patients undergoing orthopedic and gynecologic surgery	17
Minipool testing for SARS‐CoV‐2 RNA in United States blood donors	17
Effects of Intercept pathogen reduction treatment on extended cold storage of apheresis platelets	17
Hematologic evaluation of intraoperative autologous blood collection and allogeneic transfusion in cardiac surgery	17
Multi‐national survey of transfusion experiences and preferences of patients with myelodysplastic syndrome	17
A prospective observational study of the incidence, natural history, and risk factors for intravenous immunoglobulin‐mediated hemolysis	17
The impact of ABO blood groups on clinical outcomes and susceptibility to COVID‐19: A retrospective study in an unselected population	17
Detection of BabesiaRNA and DNA in whole blood samples from US blood donations	16
New blood donors in times of crisis: Increased donation willingness, particularly among people at high risk for attracting SARS‐CoV‐2	16
From demand forecasting to inventory ordering decisions for red blood cells through integrating machine learning, statistical modeling, and inventory optimization	16
Frequent platelet donation is associated with lymphopenia and risk of infections: A nationwide cohort study	16
Transfusion support in COVID‐19 patients: Impact on hospital blood component supply during the outbreak	16
Convalescent plasma treatment of critically ill intensive care COVID‐19 patients	16
Retention of hemostatic and immunological properties of frozen plasma and COVID‐19 convalescent apheresis fresh‐frozen plasma produced and freeze‐dried in Canada	15
ABO blood type association with SARS‐CoV‐2 infection mortality: A single‐center population in New York City	15
A large cohort study of the effects of Lewis, ABO, 13 other blood groups, and secretor status on COVID‐19 susceptibility, severity, and long COVID‐19	15
Are We Forgetting About IgA? A Re‐examination of Coronavirus Disease 2019 Convalescent Plasma	15
Fetomaternal hemorrhage: Evidence from a multihospital healthcare system that up to 40% of severe cases are missed	15
Whole truths but half the blood: Addressing the gap between the evidence and practice of pre‐hospital and in‐hospital blood product use for trauma resuscitation	15
How do I implement an outpatient program for the administration of convalescent plasma for COVID‐19?	15
Refrigeration of apheresis platelets in platelet additive solution (PAS‐E) supports in vitro platelet quality to maximize the shelf‐life	15

Acquired platelet storage container leaks and contamination with environmental bacteria: A preventable cause of bacterial sepsis	15
Plasmavigilance—Adverse events among US Source plasma donors	15
Tranexamic acid: Beyond antifibrinolysis	15
COVID‐19 antibody screening with SARS‐CoV‐2 red cell kodecytes using routine serologic diagnostic platforms	14
Transfusion‐associated hyperkalemia in pediatric population: Prevalence, risk factors, survival, infusion rate, and RBC unit features	14
Antioxidant prevents clearance of hemostatically competent platelets after long‐term cold storage	14
Transfusion reactions associated with COVID‐19 convalescent plasma therapy for SARS‐CoV‐2	14
Massive transfusions and severe hypocalcemia: An opportunity for monitoring and supplementation guidelines	14
Pandemic blood donor demographics – Do changes impact blood safety?	13
What would it take to convince you to donate? A survey study of the relationship between motivators, barriers, and payment for whole blood, plasma, and platelet donation	13
Improvements and limitations in developing multivariate models of hemorrhage and transfusion risk for the obstetric population	13
Donation‐induced iron depletion is significantly associated with low hemoglobin at subsequent donations	13
A trend of dropping anti‐SARS‐CoV‐2 plaque reduction neutralization test titers over time in Canadian convalescent plasma donors	13
A prospective multi‐faceted interventional study of blood bank technologist screening of red blood cell transfusion orders: The START study	13
Improving the donation experience and reducing venipuncture pain by addressing fears among whole‐blood and plasma donors	13
Trends in hepatitis E virus infection: Analyses of the long‐term screening of blood donors in Hokkaido, Japan, 2005–2019	13
Blood group O convalescent plasma donations have significantly lower levels of SARS‐CoV‐2 IgG antibodies compared to blood group A donations	13
The role of early natural killer cell adoptive infusion before engraftment in protecting against human herpesvirus‐6B encephalitis after naïve T‐cell‐depleted allogeneic stem cel	13
Non‐invasive monitoring of red blood cells during cold storage using handheld Raman spectroscopy	13
Complement‐mediated hemolysis persists year round in patients with cold agglutinin disease	13
High‐throughput detection of antibodies targeting the SARS‐CoV‐2 Spike in longitudinal convalescent plasma samples	13
Sexual risk behavior questions: Understanding and mitigating donor discomfort	12
Hypocalcemia as a predictor of mortality and transfusion. A scoping review of hypocalcemia in trauma and hemostatic resuscitation	12
Blood shortages planning in Canada: The National Emergency Blood Management Committee experience during the first 6 months of the COVID‐19 pandemic	12
Relationship between transfusion burden, healthcare resource utilization, and complications in patients with beta‐thalassemia in Taiwan: A real‐world analysis	12
Multidisciplinary management of anti‐PP1Pk or anti‐P alloimmunization during pregnancy: A new case with anti‐P and a literature review	12
Impact of COVID‐19 and lockdown regarding blood transfusion	12
Safety profile of low‐titer group O whole blood in pediatric patients with massive hemorrhage	12
Peri‐transfusion quality‐of‐life assessment for patients with myelodysplastic syndromes	12
Conservation of Rh negative Low Titer O Whole Blood (LTOWB) and the need for a national conversation to define its use in trauma transfusion protocols	12
Metabolic rejuvenation upgrades circulatory functions of red blood cells stored under blood bank conditions	12
A survey of US hospitals on platelet inventory management, transfusion practice, and platelet availability	12
Retrospective analysis of outcomes in patients with acute hypertriglyceridemic pancreatitis treated without therapeutic plasma exchange	12
Clodronate inhibits alloimmunization against distinct red blood cell alloantigens in mice	11
Reduction of anti‐K‐mediated hemolytic disease of newborns after the introduction of a matched transfusion policy: A nation‐wide policy change evaluation study in the Netherlands	11
Initial experimental experience of triple‐knockout pig red blood cells as potential sources for transfusion in alloimmunized patients with sickle cell disease	11
Neonatal and pediatric blood bank practice in the United States: Results from the AABB pediatric transfusion medicine subsection survey	11
Removal of citrate from PAS‐III additive solution improves functional and biochemical characteristics of buffy‐coat platelet concentrates stored for 7 days, with or without INTERCEPT pathogen reductio	11
Undisclosed HIV status and antiretroviral therapy use among South African blood donors	11
Quality of evidence‐based guidelines for platelet transfusion and use: A systematic review	11
Autograft cellular composition and outcome in myeloma patients: Results of the prospective multicenter GOA study	11
Impact of the early coronavirus disease 2019 pandemic on blood utilization in the United States: A time‐series analysis of data reported to the National Healthcare Safety Network Hemovigilance Module	11
Buffy coat platelets coming to America: Are we ready?	11
Platelet CD36 deficiency is present in 2.6% of Arabian individuals and can cause NAIT and platelet refractoriness	11
Trauma‐induced hypocalcemia	11
Platelet dysfunction after trauma: From mechanisms to targeted treatment	11
Real‐world data with the use of caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura: A single‐center with homogeneous treatment experience	11
Insights intoanti‐Dformation in carriers ofRhDvariants through studies of3Dintraprotein interactions	11
COVID‐19 and the impact on blood availability and transfusion practices in low‐ and middle‐income countries	11
Effects of pathogen reduction technology and storage duration on the ability of cryoprecipitate to rescue induced coagulopathies in vitro	11
Whole blood donor behavior and availability after deferral: Consequences of a new ferritin monitoring policy	11
Proceedings of the 2022 NHLBI and OASH state of the science in transfusion medicine symposium	11
Tocilizumab in the management of posttransfusion hyperhemolysis syndrome in sickle cell disease: The experience so far	10
Toward a more complete understanding of who will benefit from prehospital transfusion	10
Diversity of variant alleles encoding Kidd, Duffy, and Kell antigens in individuals with sickle cell disease using whole genome sequencing data from the NHLBI TOPMed Program	10
Racial differences in red blood cell transfusion in hospitalized patients with anemia	10
Safety and benefits of automated red cell depletion‐exchange compared to standard exchange in patients with sickle cell disease undergoing chronic transfusion	10
Transfusion services operations during the COVID‐19 pandemic: Results from AABB survey	10
Transfusion practices for pediatric oncology and hematopoietic stem cell transplantation patients: Data from the National Heart Lung and Blood Institute Recipient Epidemiology and Donor Evaluatio	10
Civilian walking blood bank emergency preparedness plan	10
Mitigating the risk of transfusion‐transmitted infections with vector‐borne agents solely by means of pathogen reduction	10
The effect of gamma irradiation on platelet redox state during storage	10
Hormones, age, and sex affect platelet responsiveness in vitro	10
Trends and risk factors of SARS‐CoV‐2 infection in asymptomatic blood donors	10
Personalized collection of plasma from healthy donors: A randomized controlled trial of a novel technology‐enabled nomogram	10
Optimizing transfusion management of multiple myeloma patients receiving daratumumab‐based regimens	10
Evaluation of a pre‐exposure prophylaxis (PrEP)/post‐exposure prophylaxis (PEP) deferral policy among blood donors	10
Efficacy of the compensatory reserve measurement in an emergency department trauma population	10
Clinical analysis of the therapeutic effect of plasma exchange on hypertriglyceridemic acute pancreatitis: A retrospective study	10
Efficacy of early transfusion of convalescent plasma with high‐titer SARS‐CoV‐2 neutralizing antibodies in hospitalized patients with COVID‐19	10
Blood conservation strategies at United States hospitals during the COVID‐19 pandemic: Findings from a multi‐institutional analysis ‐ International Society of Blood Transfusion s	10
Familial pseudohyperkalemia induces significantly higher levels of extracellular potassium in early storage of red cell concentrates without affecting other standard measures of quality: A case contro	9
Transfusion medicine and blood banking education and training for blood establishment laboratory staff: A review of selected countries in Africa	9
Assessment of Liaison XL Murex Chagas diagnostic performance in blood screening for Chagas disease using a reference array of chimeric antigens	9
The lysophospholipid‐binding molecule CD1D is not required for the alloimmunization response to fresh or stored RBCs in mice despite RBC storage driving alterations in	9
Demographic, clinical, and biochemical predictors of pica in a large cohort of blood donors	9
Pediatric resident knowledge of transfusion medicine: Results from the BEST‐TEST3 international education needs assessment	9
Impact of the COVID‐19 pandemic on blood donation and transfusions in the United States in 2020	9
Hospital transfusion service operations during the SARS‐CoV‐2 pandemic: Lessons learned from the AABB hospital survey in preparation for the next infectious disease outbreak	9
Antibody incidence and red blood cell transfusions in patients on daratumumab	9

Too lean: Time to build back true resiliency in the national blood supply	9
Residual risk of transfusion‐transmitted hepatitis B virus (TT‐HBV) infection by NAT‐screened blood components: A review of observed versus modeled infectivity from donors with w	9
The need for an artificial oxygen carrier for disasters and pandemics, including COVID‐19	9
Missed irradiation of cellular blood components for vulnerable patients: Insights from 10 years of SHOT data	9
X‐ and gamma‐irradiation have similar effects on the in vitro quality of stored red cell components	9
Survey of the RhD selection and issuing practices for uncrossmatched blood products at pediatric trauma hospitals in the United States: The BEST collaborative study	9
Antibodies against biotin‐labeled red blood cells can shorten posttransfusion survival	9
Non‐invasive hemoglobin estimation for preoperative anemia screening	9
HIV incidence and related risks among gay, bisexual, and other men who have sex with men in Montreal, Toronto, and Vancouver: Informing blood donor selection criteria in Canada	9
Longitudinal analysis of SARS‐CoV‐2 antibodies in 8000 U.S. first‐time convalescent plasma donations	9
Anti‐D alloimmunization in Rh(D) negative adults with severe traumatic injury	9
Evaluating blood donor experiences and barriers/facilitators to blood donation in the United States using YouTube video content	9
Mouse background genetics in biomedical research: The devil's in the details	9
Staff perspectives on barriers and enablers to implementing alternative source plasma eligibility criteria for gay, bisexual, and other men who have sex with men	9
Airborne! UAV delivery of blood products and medical logistics for combat zones	9
Providing whole blood for an urban paramedical ambulance system	9
Hyporegenerative anemia in anti‐M‐associated hemolytic disease of the fetus	9
Platelet transfusions in a murine model of neonatal polymicrobial sepsis: Divergent effects on inflammation and mortality	9
A novel competition ELISA for the rapid quantification of SARS‐CoV‐2 neutralizing antibodies in convalescent plasma	8
Pathogen‐reduced platelets in pediatric and neonatal patients: Demographics, transfusion rates, and transfusion reactions	8
Associations between ABO non‐identical platelet transfusions and patient outcomes—A multicenter retrospective analysis	8
The in vitro quality of X‐irradiated platelet components in PAS‐E is equivalent to gamma‐irradiated components	8
Post‐expiry stability of freeze‐dried plasma under field conditions – Can shelf life be extended?	8
Mobilization characteristics, blood graft composition, and outcome in diffuse large B‐cell lymphoma after autologous stem cell transplantation: Results from the prospective multi	8
An analysis of outcomes for pediatric trauma warm fresh whole blood recipients in Iraq and Afghanistan	8
Detection of allergic transfusion‐related adverse events from electronic medical records	8
Rebound and overshoot of donor‐specific antibodies to human leukocyte antigens (HLA) during desensitization with plasma exchanges in hematopoietic progenitor cell transplantation: A case report	8
A possible case of recipient anti‐neutrophil and anti‐human leukocyte antigen antibody‐mediated fatal reverse transfusion‐related acute lung injury	8
The safety of COVID‐19 convalescent plasma donation: A multi‐institutional donor hemovigilance study	8
Cold‐stored platelets have better preserved contractile function in comparison with room temperature‐stored platelets over 21 days	8
Emergency transfusion with whole blood versus packed red blood cells: A study of 1400 patients	8
Platelet‐to‐red blood cell ratio and mortality in bleeding trauma patients: A systematic review and meta‐analysis	8
Results from the blood donor competence, autonomy, and relatedness enhancement (blood donor CARE) randomized trial	8
Apheresis for chimeric antigen receptor T‐cell production in adult lymphoma patients	8
Cost‐effectiveness of noninvasive fetal RhD blood group genotyping in nonalloimmunized and alloimmunized pregnancies	8
Frozen for combat: Quality of deep‐frozen thrombocytes, produced and used by The Netherlands Armed Forces 2001–2021	8
Emergency departments are higher‐risk locations for wrong blood in tube errors	8
Presence and short‐term persistence of SARS‐CoV‐2 neutralizing antibodies in COVID‐19 convalescent plasma donors	8
Platelet extracellular vesicles and their mitochondrial content improve the mitochondrial bioenergetics of cellular immune recipients	8
An assessment of hepatitis B virus prevalence in South African young blood donors born after the implementation of the infant hepatitis B virus immunization program: Implications for transfusion safet	8
Time from apheresis platelet donation to cold storage: Evaluation of platelet quality and bacterial growth	8
Compensatory reserve detects subclinical shock with more expeditious prediction for need of life‐saving interventions compared to systolic blood pressure and blood lactate	8
Bacterial contamination of blood products in Africa	8
Convalescent plasma donors show enhanced cross‐reactive neutralizing antibody response to antigenic variants of SARS‐CoV‐2 following immunization	8
The regional whole blood program in San Antonio, TX: A 3‐year update on prehospital and in‐hospital transfusion practices for traumatic and non‐traumatic he	8
Assessment of serological assays for identifying high titer convalescent plasma	8
First transfusion of cold‐stored low‐titer group O whole blood in the French armed forces	8
Hepatitis B virus prevalence in first‐time blood donors in Flanders, Belgium: Impact of universal vaccination and migration	8
Admission hypocalcemia in pediatric major trauma patients—An uncommon phenomenon associated with an increased need for urgent blood transfusion	8
The risk of thromboembolic events with early intravenous 2‐ and 4‐g bolus dosing of tranexamic acid compared to placebo in patients with severe traumatic bleeding: A secondary analysis of a randomized	8
Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet components	8
Resistance of SARS‐CoV‐2 beta and gamma variants to plasma collected from Canadian blood donors during the spring of 2020	8
Serologic characteristics of oxaliplatin antibodies in 15 patients with drug‐induced immune hemolytic anemia	8
Relationship between allergic transfusion reactions and allergic predisposition among pediatric patients with hematological/oncological disease	8
Characterization of CD177‐reactive iso‐ and auto‐antibodies	8
Implementation of measures to reduce vasovagal reactions: Donor participation and results	8
Blood far forward program: Update on French armed forces policy	8
Platelet‐enhanced plasma: Characterization of a novel candidate resuscitation fluid's extracellular vesicle content, clotting parameters, and thrombin generation capacity	8
SARS‐CoV‐2 seroprevalence among blood donors in Uganda: 2019–2022	8
Effects of red blood cell transfusion on global oxygenation in anemic critically ill patients	8
Primum, non nocere: Whole blood, prehospital transfusion and anti‐D hemolytic disease of the fetus and newborn	7
The effect of the SARS‐CoV‐2 pandemic and civil unrest on massive transfusion protocol activations in Minneapolis 2020	7
Climate change and parasitic risk to the blood supply	7
Staphylococcus epidermidisundergoes global changes in gene expression during biofilm maturation in platelet concentrates	7
Neutralizing activity to SARS‐CoV‐2 of convalescent and control plasma used in a randomized controlled trial	7
Racial differences in transfusion practices: Time to address structural racism	7
Hospital red blood cell and platelet supply and utilization from March to December of the first year of the COVID‐19 pandemic: The BEST collaborative study	7
The relationship between glycosylated hemoglobin level and red blood cell storage lesion in blood donors	7
A single‐center, retrospective analysis of 17 cases of hemolytic disease of the fetus and newborn caused by anti‐M antibodies	7
Blood component use and injury characteristics of acute trauma patients arriving from the scene of injury or as transfers to a large, mature US Level 1 trauma center serving a large, geogra	7
Potentially modifiable predictors of cell collection efficiencies and product characteristics of allogeneic hematopoietic progenitor cell collections	7
Prolonged storage of purified granulocyte concentrates: Introduction of a new purification method	7
Antibody profiles in COVID‐19 convalescent plasma prepared with amotosalen/UVA pathogen reduction treatment	7
The Norwegian blood preparedness project: A whole blood program including civilian walking blood banks for early treatment of patients with life‐threatening bleeding in municipal health care services,	7
Survey of newborn direct antiglobulin testing practice in United States and Canadian transfusion services	7
Influence of laboratory procedures on postthawing cell viability and hematopoietic engraftment after autologous peripheral blood stem cell transplantation	7
Benefits of lower neonatal platelet transfusion thresholds	7
A survey of low titer O whole blood use within the trauma quality improvement program registry	7
Non‐transfusion dependent thalassemia is independently associated with higher alloimmunization risk than transfusion dependent thalassemia and would benefit the most from extended red cell antigen‐mat	7
Frequency of rare, serious donor reactions: International perspective	7
ABO blood group does not influence the level of anti‐SARS‐CoV‐2 antibodies in convalescent plasma donors	7
Occult and active hepatitis B virus detection in donated blood in São Paulo, Brazil	7
Low titer Group O whole blood utilization in pediatric trauma resuscitation: A National Survey	7
Could antigen loss be a potential mechanism to explain antibody‐mediated immune suppression?	7
COVID‐19 convalescent plasma donor characteristics, product disposition, and comparison with standard apheresis donors	7
Platelet transfusion refractoriness and anti‐HLA immunization	7
A national level estimation of population need for blood in India	7
Mortality and morbidity in non‐transfusable and transfusable patients: A systematic review and meta‐analysis	7
Human platelets labeled at two discrete biotin densities are functional in vitro and are detected in vivo in the murine circulation: A promising approach to monitor platelet survival in vivo in clinic	7
Comparison of prenatal anti‐D titration testing by gel and tube methods: A review of the literature	7
Fear is associated with attrition of first‐time whole blood donors: A longitudinal examination of donor confidence and attitude as potential mediators	7
Pathogen reduction technologies need to evaluate Fc‐mediated antibody functions	7
Willingness of blood donors in Australia to provide additional data and blood sample for health research	7
Osmotic hemolysis is a donor‐specific feature of red blood cells under various storage conditions and genetic backgrounds	7
Blood donation motivators and barriers reported by young, first‐time whole blood donors: Examining the association of reported motivators and barriers with subsequent donation behavior and potential s	7